Scientists who engineered a ‘100% lethal’ H5N1 bird flu virus in mammals at a South Korean university are now issuing dire warnings that it may now start spreading among humans, following the country’s first recorded wild mammal death from the virus—occurring suspiciously right after their deadly experiments. This alarming escalation raises red flags about lab leaks and biosafety failures, as the pathogen jumps species in a way that mirrors their gain-of-function research.
In this report, I break down the timeline and connections, showing documents that link the university’s creation of a hyper-lethal strain to the infection, highlighting the proximity in time, location, personnel, and pathogen design that demands scrutiny. Watch as I explain why these coincidences aren’t mere chance, especially amid global health authorities’ aggressive push for bird flu vaccines, which could capitalize on manufactured fear while ignoring the potential origins of this engineered threat.
Modernity.news reports:
BYPASS THE CENSORS
Sign up to get unfiltered news delivered straight to your inbox.
You can unsubscribe any time. By subscribing you agree to our Terms of Use
- Mar 18, 2025: Leopard cat found moribund; H5N1 confirmed in lungs and brain (Frontiers in Veterinary Science, July 2025).
- Same scientists, same university: Konkuk University researchers who reported the leopard’s infection had already completed gain-of-function experiments making H5N1 100% lethal in mammals, specifically targeting the brain (Virology Journal, June 2025).
- Lab strain caused fatal neurological damage in mice; wild leopard cat infection found in the same organ targeted in their experiments.
- Second high-risk study: May 2025 Virology Journal paper from another South Korean institution created a chimeric, “Frankenstein” H5N1 strain with heat resistance, altered receptor binding, boosted replication, and record-breaking human cell entry.
- Tight timeline: Both gain-of-function projects were completed before or around the leopard’s infection and death.
- No public record of gain-of-function review, biosafety audit, or independent investigation.
- Pattern emerges: Same country. Same viral clade. Same type of enhancements. Same scientists. Same organ targeted. First wild mammal fatality follows closely after.
